Press release
Overactive Bladder - Pipeline Review, H1 2017; New Report Launched
DrugPipeline.net
Overactive bladder is a problem with bladder-storage function that causes a sudden urge to urinate. The urge may be difficult to stop, and overactive bladder may lead to the involuntary loss of urine (incontinence). Symptoms include feel a sudden urge to urinate that's difficult to control, experience urge incontinence and awaken two or more times in the night to urinate. Treatment includes change in life style and medications that relax the bladder can be effective for relieving symptoms of overactive bladder and reducing episodes of urge incontinence.
Report Highlights
Pharmaceutical and Healthcare latest pipeline guide Overactive Bladder - Pipeline Review, H1 2017, provides comprehensive information on the therapeutics under development for Overactive Bladder (Genito Urinary System And Sex Hormones), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.
The Overactive Bladder (Genito Urinary System And Sex Hormones) pipeline guide also reviews of key players involved in therapeutic development for Overactive Bladder and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Pre-Registration, Phase III, Phase II, Phase I, IND/CTA Filed, Preclinical, Discovery and Unknown stages are 2, 7, 5, 5, 2, 11, 1 and 1 respectively. Similarly, the Universities portfolio in Preclinical stages comprises 1 molecules, respectively.
Overactive Bladder (Genito Urinary System And Sex Hormones) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from Publisher’s proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.
Scope
- The pipeline guide provides a snapshot of the global therapeutic landscape of Overactive Bladder (Genito Urinary System And Sex Hormones).
- The pipeline guide reviews pipeline therapeutics for Overactive Bladder (Genito Urinary System And Sex Hormones) by companies and universities/research institutes based on information derived from company and industry-specific sources.
- The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
- The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
- The pipeline guide reviews key companies involved in Overactive Bladder (Genito Urinary System And Sex Hormones) therapeutics and enlists all their major and minor projects.
- The pipeline guide evaluates Overactive Bladder (Genito Urinary System And Sex Hormones) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.
- The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
- The pipeline guide reviews latest news related to pipeline therapeutics for Overactive Bladder (Genito Urinary System And Sex Hormones)
Reasons to buy
- Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.
- Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
- Find and recognize significant and varied types of therapeutics under development for Overactive Bladder (Genito Urinary System And Sex Hormones).
- Classify potential new clients or partners in the target demographic.
- Develop tactical initiatives by understanding the focus areas of leading companies.
- Plan mergers and acquisitions meritoriously by identifying key players and it’s most promising pipeline therapeutics.
- Formulate corrective measures for pipeline projects by understanding Overactive Bladder (Genito Urinary System And Sex Hormones) pipeline depth and focus of Indication therapeutics.
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
- Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from pipeline.
Spanning over 114 pages “Overactive Bladder - Pipeline Review, H1 2017” report covers Introduction, Report Coverage, Overactive Bladder - Overview, Overactive Bladder - Therapeutics Development, Appendix, Methodology. The report covered companies are - Addex Therapeutics Ltd, Allergan Plc, Asahi Kasei Pharma Corp, Astellas Pharma Inc, Dompe Farmaceutici SpA, Dong-A ST Co., Ltd., FemmePharma Global Healthcare Inc, Hanmi Pharmaceuticals Co Ltd, Hydra Biosciences Inc
For more information Visit at: http://www.drugpipeline.net/global-markets-direct/overactive-bladder-pipeline-review-h1-2017
Find all Diseases Reports at - http://www.drugpipeline.net/catalog/diseases
About DrugPipeline.net
DrugPipeline.net is a market research reports distribution platform which hosts research reports from all leading global market research firms related to pharma industry. It also assist decision makers locate the right market research solution from a single place.
Mr. Sudeep Chakravarty
Director - Operations
DrugPipeline.net
http://www.drugpipeline.net
Tel USA: +1-302-703-9904
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Overactive Bladder - Pipeline Review, H1 2017; New Report Launched here
News-ID: 556924 • Views: …
More Releases from DrugPipeline.net
Global HLA Typing Transplant Market 2017-2021; New Report Launched
DrugPipeline.net has announced the addition of “Global HLA Typing Transplant Market 2017-2021” research report to their website www.DrugPipeline.net
Human leukocyte antigen (HLA) is located in the chromosome 6, which is present in almost all nucleated cells. The HLA system includes a complex array of genes, which controls the immune response through recognition of self and non-self antigens, which can lead to graft rejection. HLA typing, also known as tissue typing, is…
Global Surgical Instrument Tracking System Market Research Report 2017; New Repo …
DrugPipeline.net has announced the addition of “Global Surgical Instrument Tracking System Market Research Report 2017” research report to their website www.DrugPipeline.net
Global Surgical Instrument Tracking System Market Research Report 2017, report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Surgical Instrument Tracking System in these regions, from 2012 to 2022 (forecast), covering
North America
Europe
China
Japan
Southeast Asia
India
Global Surgical Instrument Tracking System market competition by…
Global Orthopedic Navigation Systems Sales Market Report 2017; New Report Launch …
Global Orthopedic Navigation Systems Sales Market Report 2017, report split global into several key Regions, with sales (K Units), revenue (Million USD), market share and growth rate of Orthopedic Navigation Systems for these regions, from 2012 to 2022 (forecast), covering
United States
China
Europe
Japan
Southeast Asia
India
Global Orthopedic Navigation Systems market competition by top manufacturers/players, with Orthopedic Navigation Systems sales volume, Price (USD/Unit), revenue (Million USD) and market share for each manufacturer/player; the top players…
More Releases for Overactive
Overactive Bladder (OAB) - Drug Pipeline Landscape, 2022
Overactive bladder (OAB) is a condition in which the bladder muscle contracts too often and causes urinary frequency, urgency, and incontinence. It affects both men and women, but is more common in women.
The causes of overactive bladder include neurological disorders, such as stroke, multiple sclerosis and eak pelvic muscles, diabetes, urinary tract infections, excess consumption of caffeine or alcohol, declining cognitive function due to aging, difficulty walking.
The most common symptoms…
Overactive Bladder Treatment Market Size, Forecast Report 2022 - 2030
Acumen Research and Consulting has announced the addition of the "Overactive Bladder (OAB) Treatment Market" report to their offering.
The Overactive Bladder (OAB) Treatment Market Report 2030 is an in depth study analyzing the current state of the Overactive Bladder (OAB) Treatment Market. It provides brief overview of the market focusing on definitions, market segmentation, end-use applications and industry chain analysis. The study on Overactive Bladder (OAB) Treatment Market provides analysis…
US Overactive Bladder Market Analysis with Research Report 2020
The US Overactive Bladder Market research study is segmented on the basis of applications, technology, geography and types. The report provides a detailed Overactive Bladder Industry Overview along with the analysis of industry's gross margin, cost structure, consumption value, and sale price. The leading companies of the Overactive Bladder Market, manufacturers, and distributors are profiled in the report along with the latest Industry development current and future trends.
The U.S. OAB…
Overactive Bladder (OAB) Treatment- Global Market Outlook 2019-2024
Global Overactive Bladder Treatment Market, delivering a must-read report for industry stakeholders wanting to understand the strategic landscape of this burgeoning sector. Readers will find an in-depth analysis of the market and how it will impact existing traditional markets, as well as insights into future development and opportunities across the globe.
MarketInsightsReports has announced the addition of the "Global Overactive Bladder Treatment Market Research Report 2018" The report focuses on global…
Overactive Bladder Treatment Market-entry and market expansion strategies
MarketResearchReports.Biz adds “Global Overactive Bladder Treatment Market Share, Size, Trends and Forecast Market Research Report” reports to its database. This report provides a strategic analysis of the Overactive Bladder Treatment market and the growth estimates for the forecasted period.
Overactive bladder (OAB) is a bladder disorder that results in an abnormal urge to urinate, urinary frequency, and nocturia (voiding at night). Some patients may also experience urinary incontinence (involuntary loss of…
Global Overactive Bladder Drug Market - A Detailed Growth Analysis
Qyresearchreports include new market research report Global Overactive Bladder Drug Market Size, Status and Forecast 2022 to its huge collection of research reports.
The report on the global Overactive Bladder Drug market offers a comprehensive insight into the current market outlook, emerging demand dynamics, share and size of various segments, and the competitive landscape. The elaborate analysis of the Overactive Bladder Drug market includes an assessment of various business risks, particularly…
